questionText: To ask the Secretary of State for Health and Social Care, what progress he has made on the development of a clinical policy relating to the use of abiraterone acetate as a first-line treatment for men with locally advanced high-risk prostate cancer; and w
answerText: NHS England has developed a policy proposal for abiraterone acetate and prednisolone to be used as a routine commissioning treatment option for high-risk, hormone sensitive, non-metastatic prostate cancer.In line with NHS England’s service development pro...
heading: Prostate Cancer: Drugs